MedTrace Logo

Effect of Gastric Bypass on Patients With Type 2 Diabetes and/or Dyslipidemia

NCT00879125 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 219

Last updated 2009-09-14

No results posted yet for this study

Summary

This is a retrospective review of patients who have undergone bariatric surgery at VUMC and who have type 2 Diabetes and/or dyslipidemia. The investigators have previously found that gastric bypass significantly improves diabetes 6-12 months after surgery. The investigators are interested in looking at the longer term results after surgery.

Conditions

Sponsors & Collaborators

  • Vanderbilt University

    lead OTHER

Principal Investigators

  • William O Richards, MD · Vanderbilt University Medical Center

Eligibility

Min Age
17 Years
Max Age
66 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-11-30
Primary Completion
2007-11-30
Completion
2007-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00879125 on ClinicalTrials.gov